Latest Articles
Cannabis for pelvic pain? What’s new in endometriosis treatment - The Australian
Cannabis for pelvic pain? What’s new in endometriosis treatment The Australian
Published: June 3, 2025, 7:04 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace
Published: June 2, 2025, 11:48 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire
Published: June 2, 2025, 6:32 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo Finance
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo Finance
Published: June 2, 2025, 6:30 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo
Published: June 2, 2025, 6:30 p.m.
MSD launches phase 3 Keytruda combo trial in tough-to-treat endometrial cancer in Korea - koreabiomed.com
MSD launches phase 3 Keytruda combo trial in tough-to-treat endometrial cancer in Korea koreabiomed.com
Published: May 30, 2025, 1:52 a.m.
Clinical Guidance Paper VVOG: Pharmacological treatment of endometriosis-related pain.
Published: May 30, 2025, midnight
The Kapil Sharma Show’s Sumona Chakravarti takes a fitness retreat in Bali; calls it ‘a massive personal challenge’ - Times of India
The Kapil Sharma Show’s Sumona Chakravarti takes a fitness retreat in Bali; calls it ‘a massive personal challenge’ Times of India
Published: May 29, 2025, 11:30 p.m.
The Kapil Sharma Show’s Sumona Chakravarti takes a fitness retreat in Bali; calls it ‘a massive personal - Times of India
The Kapil Sharma Show’s Sumona Chakravarti takes a fitness retreat in Bali; calls it ‘a massive personal Times of India
Published: May 29, 2025, 11:30 p.m.
Long-term Commitment to Treating Endometriosis and Improving Women's Quality of Life - Gedeon Richter at the World Congress on Endometriosis - The Malaysian Reserve
Long-term Commitment to Treating Endometriosis and Improving Women's Quality of Life - Gedeon Richter at the World Congress on Endometriosis The Malaysian Reserve
Published: May 29, 2025, 9:20 a.m.
Link copied to clipboard!